vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and PLAYSTUDIOS, Inc. (MYPS). Click either name above to swap in a different company.

PLAYSTUDIOS, Inc. is the larger business by last-quarter revenue ($55.4M vs $38.9M, roughly 1.4× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs -24.7%, a 49.4% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -18.3%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $3.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -15.6%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.

CDXS vs MYPS — Head-to-Head

Bigger by revenue
MYPS
MYPS
1.4× larger
MYPS
$55.4M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+99.6% gap
CDXS
81.3%
-18.3%
MYPS
Higher net margin
CDXS
CDXS
49.4% more per $
CDXS
24.7%
-24.7%
MYPS
More free cash flow
CDXS
CDXS
$16.0M more FCF
CDXS
$19.6M
$3.6M
MYPS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-15.6%
MYPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
MYPS
MYPS
Revenue
$38.9M
$55.4M
Net Profit
$9.6M
$-13.7M
Gross Margin
94.8%
Operating Margin
27.1%
-17.7%
Net Margin
24.7%
-24.7%
Revenue YoY
81.3%
-18.3%
Net Profit YoY
192.5%
38.9%
EPS (diluted)
$0.13
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
MYPS
MYPS
Q4 25
$38.9M
$55.4M
Q3 25
$8.6M
$57.6M
Q2 25
$15.3M
$59.3M
Q1 25
$7.5M
$62.7M
Q4 24
$21.5M
$67.8M
Q3 24
$12.8M
$71.2M
Q2 24
$8.0M
$72.6M
Q1 24
$17.1M
$77.8M
Net Profit
CDXS
CDXS
MYPS
MYPS
Q4 25
$9.6M
$-13.7M
Q3 25
$-19.6M
$-9.1M
Q2 25
$-13.3M
$-2.9M
Q1 25
$-20.7M
$-2.9M
Q4 24
$-10.4M
$-22.4M
Q3 24
$-20.6M
$-3.1M
Q2 24
$-22.8M
$-2.6M
Q1 24
$-11.5M
$-567.0K
Gross Margin
CDXS
CDXS
MYPS
MYPS
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
MYPS
MYPS
Q4 25
27.1%
-17.7%
Q3 25
-220.3%
-13.6%
Q2 25
-83.9%
-5.9%
Q1 25
-271.6%
-4.4%
Q4 24
-34.2%
-33.1%
Q3 24
-129.0%
-6.7%
Q2 24
-284.9%
-5.5%
Q1 24
-69.6%
-2.2%
Net Margin
CDXS
CDXS
MYPS
MYPS
Q4 25
24.7%
-24.7%
Q3 25
-228.1%
-15.8%
Q2 25
-86.6%
-5.0%
Q1 25
-274.3%
-4.6%
Q4 24
-48.4%
-33.1%
Q3 24
-160.8%
-4.3%
Q2 24
-285.2%
-3.6%
Q1 24
-67.4%
-0.7%
EPS (diluted)
CDXS
CDXS
MYPS
MYPS
Q4 25
$0.13
$-0.12
Q3 25
$-0.22
$-0.07
Q2 25
$-0.16
$-0.02
Q1 25
$-0.25
$-0.02
Q4 24
$-0.12
$-0.18
Q3 24
$-0.29
$-0.02
Q2 24
$-0.32
$-0.02
Q1 24
$-0.16
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
MYPS
MYPS
Cash + ST InvestmentsLiquidity on hand
$78.2M
$104.9M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$227.9M
Total Assets
$147.8M
$290.6M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
MYPS
MYPS
Q4 25
$78.2M
$104.9M
Q3 25
$58.7M
$106.3M
Q2 25
$66.3M
$112.9M
Q1 25
$59.8M
$107.1M
Q4 24
$73.5M
$109.2M
Q3 24
$90.3M
$105.2M
Q2 24
$73.2M
$106.3M
Q1 24
$85.5M
$127.0M
Total Debt
CDXS
CDXS
MYPS
MYPS
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
MYPS
MYPS
Q4 25
$50.5M
$227.9M
Q3 25
$38.5M
$238.9M
Q2 25
$55.6M
$245.3M
Q1 25
$49.6M
$244.1M
Q4 24
$66.9M
$244.7M
Q3 24
$73.4M
$265.2M
Q2 24
$61.4M
$263.6M
Q1 24
$79.3M
$288.4M
Total Assets
CDXS
CDXS
MYPS
MYPS
Q4 25
$147.8M
$290.6M
Q3 25
$124.0M
$299.2M
Q2 25
$138.2M
$316.2M
Q1 25
$128.9M
$313.8M
Q4 24
$149.0M
$323.0M
Q3 24
$148.2M
$330.6M
Q2 24
$132.0M
$333.4M
Q1 24
$149.6M
$357.5M
Debt / Equity
CDXS
CDXS
MYPS
MYPS
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
MYPS
MYPS
Operating Cash FlowLast quarter
$20.1M
$3.7M
Free Cash FlowOCF − Capex
$19.6M
$3.6M
FCF MarginFCF / Revenue
50.3%
6.5%
Capex IntensityCapex / Revenue
1.3%
0.2%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
MYPS
MYPS
Q4 25
$20.1M
$3.7M
Q3 25
$-7.7M
$5.7M
Q2 25
$-18.0M
$13.6M
Q1 25
$-13.8M
$3.3M
Q4 24
$-16.5M
$11.6M
Q3 24
$-13.0M
$14.6M
Q2 24
$-12.2M
$14.5M
Q1 24
$-7.8M
$5.0M
Free Cash Flow
CDXS
CDXS
MYPS
MYPS
Q4 25
$19.6M
$3.6M
Q3 25
$-7.9M
$5.4M
Q2 25
$-20.5M
$13.2M
Q1 25
$-15.1M
$3.2M
Q4 24
$-18.2M
$11.5M
Q3 24
$-14.0M
$13.9M
Q2 24
$-12.6M
$12.8M
Q1 24
$-8.9M
$3.6M
FCF Margin
CDXS
CDXS
MYPS
MYPS
Q4 25
50.3%
6.5%
Q3 25
-91.7%
9.3%
Q2 25
-133.6%
22.3%
Q1 25
-199.6%
5.1%
Q4 24
-85.0%
16.9%
Q3 24
-109.0%
19.6%
Q2 24
-157.5%
17.6%
Q1 24
-52.2%
4.6%
Capex Intensity
CDXS
CDXS
MYPS
MYPS
Q4 25
1.3%
0.2%
Q3 25
2.1%
0.5%
Q2 25
16.4%
0.7%
Q1 25
16.7%
0.2%
Q4 24
8.3%
0.2%
Q3 24
7.8%
0.9%
Q2 24
5.0%
2.4%
Q1 24
6.6%
1.9%
Cash Conversion
CDXS
CDXS
MYPS
MYPS
Q4 25
2.09×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons